Antimicrobial resistance (AMR), and more specifically antibacterial resistance, poses a global challenge to human and animal health as well as to the environment. Antibiotic overuse and misuse has led to a growing number of bacteria in humans, animals and the environment that are resistant to life-saving antimicrobial therapies.
Urgent action is needed to halt the development of resistance, and to accelerate new treatments for bacterial infection. The MRC funds a wide range of research in AMR from laboratory to bedside.
But our response to this challenge has to span nations and research disciplines. The MRC has been working with the seven UK research councils, along with other UK funders, in a cross-council initiative to develop collaborative approaches across research disciplines and to identify a number of research opportunities and challenges in tackling the rise in AMR.
We also collaborate internationally with research colleagues via initiatives such as the European Joint Programming Initiative on Antimicrobial Resistance (JPI AMR) and cross-border funding partnerships such as the Newton Fund.
For all queries regarding the Antimicrobial Resistance initiative please contact:
Dr Caroline Harris - Science Manager for Antimicrobial Resistance
Dr Ghada Zoubiane - Programme Manager for Infections
- Pre-call announcement: UK-China AMR Centre Partnerships Initiative
- Pre-call announcement: UK-India AMR Initiative
- Antimicrobial Resistance in a Global Context – Call closed
- The third JPIAMR Joint Call “Transmission Dynamics
- The fourth JPIAMR call: “AMR Networks/Working Groups
- The Newton Fund UK-China AMR Partnership Initiative